United Therapeutics Corporation (UTHR)
| Previous close | 352.47 |
| Open | 352.35 |
| Bid | 352.73 x 100 |
| Ask | 353.66 x 100 |
| Day's range | 352.35 - 357.31 |
| 52-week range | 208.62 - 366.08 |
| Volume | |
| Avg. volume | 454,582 |
| Market cap | 15.731B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 16.26 |
| EPS (TTM) | 21.75 |
| Earnings date | 30 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 367.52 |
Insider MonkeyUnited Therapeutics Corporation (UTHR): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now?
We recently compiled a list of the 8 Best Cheap Growth Stocks To Invest In Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the other cheap growth stocks. What Should Your Portfolio Look Like in the Current Bull Market The current market data shows that […]
- Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 24, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five presentations and one poster across its commercial and development portfolio will be presented at the CHEST 2024 Annual Meeting hosted by the American College of Chest Physicians taking place October 6-9, 2024, in Boston. United Therapeutics will sponsor the Tyvaso DPI®: Clinical Pearls and Drug-Device Characteristics Sympo
- Insider Monkey
United Therapeutics (UTHR) Is Thriving on Strong Demand and Smart Pricing
We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best mid cap growth stocks. 50 Basis Point Reduction: Exaggeration or Hidden Benefit? Recent discussions among financial strategists emphasize the current […]
